Presymptomatic prediction of sepsis in intensive care unit patients

Clinical and Vaccine Immunology

Volumn 15, Issue 7, 2008, Pages 1089-1094

  Lukaszewski, R A ^a   Yates, A M ^a   Jackson, M C ^a   Swingler, K ^b   Scherer, J M ^a   Simpson, A J ^a   Sadler, P ^c   McQuillan, P ^c   Titball, R W ^e   Brooks, T J G ^d   Pearce, M J ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b UNIVERSITY OF STIRLING   (United Kingdom)

^c QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; BLOOD SAMPLING; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; FEMALE; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEPSIS;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; CYTOKINES; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; SEPSIS;

EID: 47649096699     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00486-07     Document Type: Article

References (42)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. 1992. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20:864-874.
2. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clemont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis, outcome, and associated costs of critical care. Crit. Care Med. 29:1303-1310.
3. Berner, R., R. Neimeyer, J. U. Leititus, A. Funke, C. Schwab, U. Rau, K. Richter, M. S. Tawfeek, A. Clad, and M. Brandis. 1998. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8 and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr. Res. 44:469-477.
4. Bjerre, A., B. Bruslett, E. A. Hoiby, P. Kierulf, and P. Brandtzaeg. 2004. Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock. Crit. Care Med. 32:433-438.
5. Boldrick, J. C., A. A. Alizadeh, M. Diehn, S. Dudoit, C. L. Liu, C. E. Belcher, D. Bolstein, L. M. Staudt, P. O. Brown, and D. A. Relman. 2002. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc. Natl. Acad. Sci. USA 99:972-977.
6. Bossink, A. W., L. Paeman, P. M. Jansen, C. E. Hack, L. G. Thijs, and J. Van Damme. 1995. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 86:3841-3847.
7. Brunkhorst, F. M., K. Wegscheider, Z. F. Forycki, and S. D. Anker. 2000. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med. 26:S148-S152.
8. Calvano, S. E., W. Xiao, D. R. Richards, R. M. Felciano, H. V. Baker, R. J. Cho, R. O. Chen, B. H. Brownstein, J. P. Cobb, S. K. Tschoeke, C. Miller-Graziano, L. L. Moldawer, M. N. Mindrinos, R. W. Davis, R. G. Tompkins, S. F. Lowry, and Inflamm. and Host Response to Injury Large Scale Collab. Res. Program. 2005. A network-based analysis of systemic inflammation in humans. Nature 437:1032-1037.
9. Chaussabel, D., R. T. Semnani, M. A. McDowell, D. Sacks, A. Sher, and T. B. Nutman. 2003. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 102:672-681.
10. Chinnaiyan, A. M., M. Huber-Lang, C. Kumar-Sinha, T. R. Barrette, S. Shankar-Sinha, V. J. Sarma, V. A. Padgaonkar, and P. A. Ward. 2001. Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am. J. Pathol. 159:1199-1209.
11. Claeys, R., S. Vinken, H. Spapen, K. ver Elst, K. Decochez, L. Huyghens, and F. K. Gorus. 2002. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit. Care Med. 30:757-762.
12. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420:885-891.
13. Damas, P., D. Ledoux, M. Nys, Y. Vrindts, D. De Groote, P. Franchimont, and M. Lamy. 1992. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215:356-362.
14. Damas, P., A. Reuter, P. Gysen, J. Demonty, M. Lamy, and P. Franchimont. 1989. Tumour necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17:975-978.
15. Das, U. N. 2006. Can sepsis and other critical illnesses be predicted and prognosticated? Adv. Sepsis 5:52-59.
16. De Freitas, I., M. Fernandez-Samoza, E. Essenfield-Sekler, and J. E. Cardier. 2004. Serum levels of the apoptosis-associated molecules, tumour necrosis factor-(alpha)/tumour necrosis factor type I receptor and Fas/FasL, in sepsis. Chest 125:2238-2246.
17. Dhainaut, J. F., Y. E. Claessens, J. Janes, and D. R. Nelson. 2005. Underlying disorders and their impact on the host response to infection. Clin. Infect. Dis. 41:S481-S497.
18. Dybowski, R., R. Weller, R. Chang, and V. Gant. 1996. Prediction of outcome in critically ill patients using artificial neural network synthesised by genetic algorithm. Lancet 347:1146-1150.
19. Feezor, R. J., C. Oberholzer, H. V. Baker, D. Novick, M. Rubinstein, L. L. Moldawer, J. Pribble, S. Souza, C. A. Dinarello, W. Ertel, and A. Oberholzer. 2003. Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect. Immun. 71:5803-5813.
20. Fujishima, S., J. Sasaki, Y. Shinozawa, K. Takuma, H. Kimura, M. Suzuki, M. Kanazawa, S. Hori, and N. Aikawa. 1996. Serum MIP-1 alpha and IL-8 in septic patients. Intensive Care Med. 22:1169-1175.
21. Griffiths, M. J., M. J. Shaffi, S. J. Popper, C. A. Hemingway, M. M. Kortok, A. Wathen, K. A. Rockett, R. Mott, M. Levin, C. R. Newton, K. Marsh, D. A. Relman, and D. P. Kwiatkowski. 2005. Genomewide analysis of the host response to malaria in Kenyan children. J. Infect. Dis. 191:1599-1611.
22. Holmes, C. J., J. Russell, and K. R. Walley. 2003. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124:1103-1115.
23. Kabir, K., H. Keller, G. Grass, T. Minor, F. Steuber, S. Schroeder, C. Putensen, C. Paul, C. Burger, C. Rangger, L. F. Neville, and G. Matthiak. 2003. Cytokines and chemokines in serum and urine as early predictors to identify septic patients on intensive care unit. Int. J. Mol. Med. 12:565-570.
24. Levy, M. M., M. P. Fink, J. C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S. M. Opal, J. L. Vincent, and G. Ramsay. 2003. 2001SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31:1250-1256.
25. Lisboa, P. J. G. 2002. A review of evidence of health benefit from artificial neural networks in medical intervention. Neural Netw. 15:11-39.
26. Mendis, C., R. Das, R. Hammamei, A. Royaee, D. Yang, S. Peel, and M. Jett. 2005. Transcriptional response signature of human lymphoid cells to staphylococcal enterotoxin B. Genes Immun. 6:84-94.
27. Muller, B., K. L. Becker, H. Schachinger, P. R. Rickenbacher, P. R. Huber, W. Zimmerli, and R. Ritz. 2000. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit. Care Med. 28:977-983.
28. Nau, G. J., J. F. Richmond, A. Schlesinger, E. G. Jennings, E. S. Lander, and R. A. Young. 2002. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 99:1503-1508.
29. Neely, A. N., L. A. Fowler, R. J. Kagan, and G. D. Warden. 2004. Procalcitonin in pediatric burn patients: an early indicator of sepsis? J. Burn Care Rehabil. 25:76-80.
30. Peltola, H., and M. Jaakkola. 1988. Serious bacterial infections. C-reactive protein as a serial index of severity. Clin. Pediatr. 27:532-537.
31. Ramilo, O., W. Allman, W. Chung, A. Mejias, M. Ardura, C. Glaser, K. M. Wittkowski, B. Piqueras, J. Banchereau, A. K. Palucka, and D. Chaussabel. 2007. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109:2066-2077.
32. Reghunathan, R., M. Jayapal, L. Y. Hsu, H. H. Chng, D. Tai, B. P. Leung, and A. J. Melendez. 2005. Expression profile of immune response genes in patients with severe acute respiratory syndrome. BMC Immunol. 6:2.
33. Rodriguez-Gaspar, M., F. Santolaria, A. Jarque-Lopez, E. Gonzalez-Reimers, A. Milena, M. J. de la Vega, E. Rodriguez-Rodriguez, and J. L. Gomez-Sirvent. 2001. Prognostic value of cytokines in SIRS general medical patients. Cytokine 15:232-236.
34. Rubins, K. H., L. E. Hensley, P. B. Jahrlin, A. R. Whitney, T. W. Geisbert, J. W. Huggins, A. Owen, J. W. Leduc, P. O. Brown, and D. A. Relman. 2004. The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc. Natl. Acad. Sci. USA 101:15190-15905.
35. Rumelhart, D. E., and J. L. McClelland. 1986. Parallel distributed processing: explorations in the microstructure of cognition, vol. 1. Foundations. MIT Press, Cambridge, MA.
36. Sherry, R. M., J. I. Cue, J. K. Goddard, J. B. Parramore, and J. T. DiPiro. 1996. Interleukin-10 is associated with the development of sepsis in trauma patients. J. Trauma 40:613-617.
37. Toh, C. H., L. E. Ticknor, C. Downey, A. R. Giles, R. C. Paton, and R. Wenstone. 2003. Early identification of sepsis and mortality risks through simple, rapid clot wave-form analysis. Intensive Care Med. 29:55-61.
38. Uzzan, B., R. Cohe, P. Nicolas, M. Cucherat, and G. Y. Perret. 2006. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit. Care Med. 34:1996-2003.
39. van Dissel, J. T., P. van Langevelde, R. G. J. Westendorp, K. Kwappenburg, and M. Frolich. 1998. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351:950-953.
40. Warner, A., M. M. Polycarpou, D. Healy, C. Verme, J. Y. Conway, and A. T. Vemuri. 1996. Multiparameter models for the prediction of sepsis outcome. Ann. Clin. Lab. Sci. 26:471-479.
41. Wells, D., and L. Kedes. 1985. Structure of human histone cDNA: evidence that basally expressed histone genes have intervening sequences and encode polyadenylated mRNAs. Proc. Natl. Acad. Sci. USA 82:2834-2838.
42. Wiersinga, W. J., M. C. Dessing, P. A. Kager, A. C. Cheng, D. Limmathurotsakul, N. P. Day, A. M. Dondorp, T. van der Poll, and S. J. Peacock. 2007. High-throughput mRNA profiling characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia pseudomallei. Infect. Immun. 75:3074-3079.